Pulmonary Disease in a Psychiatric Inpatient Population

Chronic Obstructive Airway Disease Clinical Trial

Official title:

Pulmonary Disease in a Psychiatric Inpatient Population, a Screening Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01823627
• Other study ID #: SJ-322
• Status: Completed
• Phase: N/A
• Start date: March 2013
• Est. completion date: July 2013

Study information

• Verified date: May 2018
• Source: Psykiatrien Syd
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking.

Hypothesis

Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history

Method:

80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: July 2013
• Est. primary completion date: June 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Inpatients in Psykiatrien Syd, Region Zealand, ward S1,S2,S3,S4,S5,S6

• Admission time over 48 hours

Exclusion Criteria:

• Patients who is not able to perform spirometry due to their psychiatric condition

Related Conditions & MeSH terms

• Chronic Obstructive Airway Disease
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Procedure:
• Spirometry with reversibility test
Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration

Locations

Country	Name	City	State
Denmark	Psyciatrien Syd, Region Zealand	Vordingborg

Sponsors (2)

Lead Sponsor	Collaborator
Psykiatrien Syd	Naestved Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tiffeneau index	- FEV1/FVC ratio	at enrollment
Secondary	forced vital capacity	FVC L/s	at enrollment
Secondary	Forced expiratory volume in 1 second	FEV1 L	at enrollment